Difficulty: Medium
Average Score: 88%
Practice
A pulmonary embolus occurring while the patient is on the combined oral contraceptive pill:
Correct answer
A
Rationale
The correct answer is A) Is more likely in anti-thrombin III deficiency.
Rationale:
Anti-thrombin III is a natural anticoagulant that inhibits blood clot formation. When deficient, there is an increased risk of developing blood clots, including pulmonary embolism. Combined oral contraceptive pills contain estrogen and progestin, which further increase the risk of thrombosis by promoting clotting factors. Therefore, in a patient with anti-thrombin III deficiency, the risk of developing a pulmonary embolus while on the combined pill is significantly higher.
B) Is more likely in protein C deficiency: Protein C is also an anticoagulant protein, but its deficiency typically leads to an increased risk of venous thrombosis rather than pulmonary embolism specifically in the context of oral contraceptive use.
C) Is an absolute contraindication to the combined pill: While a history of pulmonary embolism would be a contraindication to estrogen-containing contraceptives, an acute event like a pulmonary embolus occurring while on the pill does not necessarily make it an absolute contraindication.
D) Is an increased risk in smokers: Smoking is a well-known risk factor for cardiovascular diseases, including venous thromboembolism. However, the primary factor in this scenario is the underlying anti-thrombin III deficiency rather than smoking status alone.
Educational Context:
Understanding the interaction between pharmacological agents like oral contraceptives and underlying conditions such as coagulation disorders is crucial in pediatric cardiovascular nursing. This knowledge helps in assessing risks, making informed decisions about treatment options, and providing safe and effective care to pediatric patients with complex medical needs.
Rationale:
Anti-thrombin III is a natural anticoagulant that inhibits blood clot formation. When deficient, there is an increased risk of developing blood clots, including pulmonary embolism. Combined oral contraceptive pills contain estrogen and progestin, which further increase the risk of thrombosis by promoting clotting factors. Therefore, in a patient with anti-thrombin III deficiency, the risk of developing a pulmonary embolus while on the combined pill is significantly higher.
B) Is more likely in protein C deficiency: Protein C is also an anticoagulant protein, but its deficiency typically leads to an increased risk of venous thrombosis rather than pulmonary embolism specifically in the context of oral contraceptive use.
C) Is an absolute contraindication to the combined pill: While a history of pulmonary embolism would be a contraindication to estrogen-containing contraceptives, an acute event like a pulmonary embolus occurring while on the pill does not necessarily make it an absolute contraindication.
D) Is an increased risk in smokers: Smoking is a well-known risk factor for cardiovascular diseases, including venous thromboembolism. However, the primary factor in this scenario is the underlying anti-thrombin III deficiency rather than smoking status alone.
Educational Context:
Understanding the interaction between pharmacological agents like oral contraceptives and underlying conditions such as coagulation disorders is crucial in pediatric cardiovascular nursing. This knowledge helps in assessing risks, making informed decisions about treatment options, and providing safe and effective care to pediatric patients with complex medical needs.